Scientists have published a new, peer-reviewed article that supports alternative approaches for Alzheimer’s disease – and counteracts claims by “potentially doctored” images.
The new publication in Molecular Psychiatry comes just weeks after an investigation uncovered possible tampering and the falsification of images which could damage long-held beliefs about the causes of Alzheimer’s – including Genuv’s hypothesis.
But this most recent piece, it is claimed, provides validation of Genuv’s novel neuro-protection approach to Alzheimer’s and offers a new approach to treating the disease.
The results showed that mice with a human form of Alzheimer’s that were treated with Genuv’s SNR1611 drug candidate were able to preserve existing brain cells.
The mice actually regained neural and cognitive functions that had been lost to the disease, as shown by maze tests and an ability to recognise new objects placed in their environment.
The new research provides important validation for the company’s six-year effort to develop new treatments for neurodegenerative diseases including Alzheimer’s disease (AD) and amyotrophic lateral sclerosis (ALS).
Who is Genuv?
Genuv Inc is a Korean, clinical-stage biotechnology company focused on innovative drug discovery for central nervous system disorders. It also specialises in advanced antibody therapies for immuno-oncology.
Founder and CEO Dr Sungho Han commented: “We are excited to share these extremely encouraging preclinical results.
“We believe we have demonstrated early proof of a new approach to neurodegenerative disease, focused on neuro-protection and neurogenesis.
“We plan to continue our pre-clinical exploration of MEK 1/2 inhibitors.”
Dr. Han is a member of the team that conducted the research into SNR1611. All research relevant to the publication was conducted in Genuv’s laboratories or under Genuv’s supervision.
SNR1611 is currently in a Phase 1/2a clinical trial in Korea for ALS.
Previously on Health Tech World:
Digital twins set to advance stroke care
Can AI help keep the human experience in social care?
mRNA discovery paves the way to safer vaccines
Eye scans provide crucial insights into kidney health
Key tips for accelerating the health security compliance journey
Nordic Consulting strengthens team in Ireland
Healthcare innovators and leaders honoured at Imprivata HealthCon user group and awards ceremony
Wearable communication system may reduce digital health divide
Molecule trains the immune system to prevent cancer
Diabetes patients urged to use fitness games with caution
- News2 weeks ago
National first for openEHR portal and e-referrals solution
- Medtech4 days ago
eSight: “The technology has the potential to change someone’s life”
- News4 weeks ago
How could technology better support patient experience in the NHS?
- Entrepreneurship2 weeks ago
‘I was producing addicts every week’ – the doctor-turned-tech leader taking on the opioid crisis